Align Technology, Inc. (ALGN) Stock Price Today
Aura AI Summary
Key Stats
- $10.82BMarket Cap
- 942,127Volume
- HealthSector
- $197.5152W High
- $131.9152W Low
- 46 DaysTypical Hold Time
- $9.83BEnterprise Value
- -Div Yield
- -Trading Activity
Track Align Technology, Inc. (ALGN) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Align Technology, Inc. has traded between a low of $131.91 and a high of $197.51, highlighting its annual price range. Buy and sell Align Technology, Inc. shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Align Technology, Inc.
Align is the leading manufacturer of clear dental aligners globally, having pioneered the technology with the introduction of its Invisalign branded aligners in 1998. Since then, Invisalign has become a household name, having treated over 10 million patients with malocclusion (misaligned teeth) through orthodontist and dentist-guided treatment plans. The company maintains dominant market share of clear aligners, despite the introduction of direct-to-consumer competitors upon the expiration of key patents that began in 2017. Align also manufactures intraoral scanners (iTero), used for orthodontic treatment and restorative dental procedures (digital models for crowns, veneers, and implants).
Most Recent News
Drone defense market to hit $18.19B by 2030 with 30.6% CAGR amid rising security threats
The global drone defense system market is projected to grow from $4.72 billion in 2025 to $18.19 billion by 2030, driven by increasing unauthorized drone incidents and demand for advanced detection and countermeasure technologies. Growth is fueled by...

GE Aerospace's post-earnings dip seen as buying chance; Boeing faces tougher recovery after lowering cash flow outlook.
Jim Cramer highlights a buying opportunity in GE Aerospace following its strong Q3 orders despite a stock pullback amid industry concerns over fuel costs and interest rates. GE's commercial aerospace orders surged 58%, pushing backlog to $170 billion...

Lawsuit probes Neogen over veterinary product linked to horse deaths and FDA warning.
Pomerantz LLP is investigating Neogen Corporation after the FDA issued a warning about its veterinary wound care product, Neogen Vet HYCOAT, linked to at least 20 horse deaths due to contamination. The FDA called this the largest number of horse deat...

People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.